Search Results - I Osunkwo
- Showing 1 - 5 results of 5
-
1
-
2
S109: ACTIVATION OF PYRUVATE KINASE-R WITH ETAVOPIVAT (FT-4202) IS WELL TOLERATED, IMPROVES ANEMIA, AND DECREASES INTRAVASCULAR HEMOLYSIS IN PATIENTS WITH SICKLE CELL DISEASE TREAT... by M Telen, S Saraf, K Cruz, M Idowu, T Kalfa, I Osunkwo, R Hagar, J Geib, S Forsyth, P Schroeder, E Wu, P Kelly, R Brown
Published in HemaSphere (2022-01-01)Get full text
Article -
3
P1495: ETAVOPIVAT TREATMENT FOR UP TO 12 WEEKS IN PATIENTS WITH SICKLE CELL DISEASE IS WELL TOLERATED AND IMPROVES RED BLOOD CELL HEALTH by S. Saraf, R. C. Brown, R. W. Hagar, M. Idowu, I. Osunkwo, T. A. Kalfa, F. A. Kuypers, J. Geib, P. Schroeder, E. Wu, P. Kelly, M. J. Telen
Published in HemaSphere (2022-06-01)Get full text
Article -
4
S131: REGIONAL ASSESSMENT OF THE EXPERIENCES OF HEALTHCARE PROFESSIONALS (HCPS) TREATING PATIENTS WITH SICKLE CELL DISEASE (SCD): THE INTERNATIONAL SICKLE CELL WORLD ASSESSMENT SUR... by I Osunkwo, B Andemariam, C Minniti, F El Rassi, E Nur, A Nero, R Colombatti, M de Montalembert, M Abboud, J Arlet, S Jain, W Jastaniah, M Pita, C Trimnell, L DeBonnett, T Bailey, O Rajkovic-Hooley, B Inusa, J James
Published in HemaSphere (2022-01-01)Get full text
Article -
5
P1467: HEALTHCARE PROFESSIONALS (HCP) OPINIONS ON TREATMENTS FOR SICKLE CELL DISEASE (SCD) AND THE HCP–PATIENT RELATIONSHIP: RESULTS FROM THE INTERNATIONAL SICKLE CELL WORLD ASSESS... by B. Andemariam, J. James, C. Minniti, B. Inusa, F. El Rassi, A. Nero, C. Trimnell, M. R. Abboud, J.-B. Arlet, R. Colombatti, M. de Montalembert, S. Jain, W. Jastaniah, E. Nur, M. Pita, L. DeBonnett, T. Bailey, O. Rajkovic-Hooley, I. Osunkwo
Published in HemaSphere (2022-06-01)Get full text
Article
